Disseminated histoplasmosis in a patient with NADPH oxidase deficiency: a case report

Mohd Mujtaba Akib Bhuiyan; Mohammad Ferdous Ur Rahaman; Mahbubur Rahman; M. Nazrul Islam; Jannatara Shefa

doi:10.18203/2320-6012.ijrms20244139

Authors

Mohd Mujtaba Akib Bhuiyan Department of Internal Medicine, BSMMU, Dhaka, Bangladesh
Mohammad Ferdous Ur Rahaman Department of Internal Medicine, BSMMU, Dhaka, Bangladesh
Mahbubur Rahman Department of Internal Medicine, BSMMU, Dhaka, Bangladesh
M. Nazrul Islam Department of Radiology & Imaging, BSMMU, Dhaka, Bangladesh
Jannatara Shefa Department of Public Health & Informatics, BSMMU, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20244139

Keywords:

Neutrophil nicotinamide adenine dinucleotide phosphate, Oxidase, Chronic granulomatous diseases

Abstract

Neutrophil nicotinamide adenine dinucleotide phosphate (NADPH) Oxidase plays a pivotal role in the production of reactive oxygen species and defect of its different subunit leads to the development of chronic granulomatous diseases. The defect of different sub-units of neutrophil NADPH oxidase affects different organs1.In endemic region, histoplasmosis is often seen in host with defective cell mediated immunity. Host with primary immunodeficiency with disseminated histoplasmosis is rare. Host with primary immunodeficiency due to Neutrophil NADPH Oxidase is even rarer2.One such presentation was seen in a 49 years old man who presented to us with recurrent attacks of histoplasmosis involving different organs which was treatment refractory. We report this case so that physicians can consider correlation between primary immunodeficiency and treatment refractory disseminated histoplasmosis in a seemingly immunocompetent patient.

Metrics

Metrics Loading ...

References

Giardino G, Cicalese MP, Delmonte O, Migliavacca M, Palterer B, Loffredo L, Cirillo E, Gallo V, Violi F, Pignata C. NADPH oxidase deficiency: a multisystem approach. Oxidative medicine and cellular longevity. 2017;2017(1):4590127.

Phan AT, Bhagat A, Maknouni B, Masroor M, Hasan M. Disseminated histoplasmosis in a patient with acquired immunodeficiency syndrome in a non-endemic region (California). J Med Cases. 2023;14(7):260–4.

Paik YH, Iwaisako K, Seki E, Inokuchi S, Schnabl B, Österreicher CH, et al. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice. Hepatology. 2011;53(5):1730–41.

Montaner Ramón A, Murillo Sanjuán L, Martínez Faci C, Guerrero Laleona C, Rodríguez-Vigil Iturrate C. Serratia infections, should we think about primary immunodeficiencies? Arch Argent Pediatr. 2017;115(2):108–11.

Staudacher O, von Bernuth H. Clinical presentation, diagnosis, and treatment of chronic granulomatous disease. Front Pediatr. 2024;12:1384550.

Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-g receptor 1 deficiency. Available at: https://academic.oup.com. Accessed on 21 August 2024.

Almyroudis NG, Holland SM, Segal BH. Invasive aspergillosis in primary immunodeficiencies. Med Mycol. 2005;43 Suppl 1:S247-S259.

Fungal infections and immune deficiency. Pediatr Infect Dis. 2021;3(2):83–5.

Antachopoulos C, Walsh TJ, Roilides E. Fungal infections in primary immunodeficiencies. European J Ped. 2007;166:1099–117.

Mittal J, Ponce MG, Gendlina I, Nosanchuk JD. Histoplasma capsulatum: Mechanisms for pathogenesis. In: Current Topics in Microbiology and Immunology. Springer Verlag. 2019;2:157–91.

Dinauer MC. Primary immune deficiencies with defects in neutrophil function. Hematology 2014, the American Society of Hematology Education Program Book. 2016;2016(1):43-50.